STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

Feed excerpt — reported by STAT News

Sanders could use his linchpin role in the user fee process to push for major changes to FDA and biopharma policy.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

View MAP Context →